HIV clinical trials in Michigan
4 studies for HIV are looking for participants at sites in Michigan.
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Grosse Pointe Woods
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Henry Ford Hospital ( Site 1535), Detroit
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266831Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
- Be Well Medical Center, Berkley
- Henry Ford Health, Detroit
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07473778Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
- Be Well Medical Center, Berkley
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 14, 2026 · NCT07682961From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.